Th9 cytokines curb cervical cancer progression and immune evasion

Hum Immunol. 2019 Dec;80(12):1020-1025. doi: 10.1016/j.humimm.2019.09.009. Epub 2019 Sep 25.

Abstract

Cervical cancer is one of the most common cancers among women in developing countries. Persistent infection with high-risk human papillomavirus (HPV) is the major determinant for the development of cervical cancer. Role of newly discovered T helper 9 (Th9) cells in cervical cancer pathogenesis is yet unfolded. In this study, we observed a huge infiltration of PU.1+ cells and overrepresentation of IL-9R in tissue biopsy specimens of CIN patients in cervical cancer cases. Treatment with Th9 signatory cytokines, IL-9 and IL-21, suppressed proliferation, enhanced apoptosis and stimulated the expression of MHC I and e-cadherin on HeLa cell lines. Th9 thus seems enhance antitumor immune response through T cell cytotoxicity and play crucial role in a controlling malignant cell transformation. Therefore, this study helps in firmer understanding of relevance of Th9 in cervical cancer immunity.

Keywords: Antitumor; Cervical cancer; IL-21; IL-9; PU.1(+) cells; TILs; Th9 cells.

MeSH terms

  • Cadherins / metabolism
  • Carcinogenesis
  • Female
  • HeLa Cells
  • Humans
  • Immune Evasion
  • Immunity, Cellular
  • Interleukin-9 / metabolism*
  • Interleukins / metabolism
  • Papillomaviridae / physiology*
  • Papillomavirus Infections / immunology*
  • Receptors, Interleukin-9 / genetics
  • Receptors, Interleukin-9 / metabolism
  • T-Lymphocytes, Helper-Inducer / immunology*
  • Up-Regulation
  • Uterine Cervical Neoplasms / immunology*

Substances

  • Cadherins
  • Interleukin-9
  • Interleukins
  • Receptors, Interleukin-9
  • interleukin-21